South State Corp Amgen Inc Transaction History

South State Corp

$1.45 Billion
Q3 2024

A detailed history of South State Corp transactions in Amgen Inc stock. As of the latest transaction made, South State Corp holds 24,334 shares of AMGN stock, worth $7.17 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares

24,334

Previous 24,500 0.68%

Holding current value

$7.17 Million

Previous $7.66 Million 2.42%

% of portfolio

0.54%

Previous 0.56%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$309.38 - $337.38 $51,357 - $56,005	-166 Reduced 0.68%	24,334 $7.84 Million
Q2 2024 Aug 02, 2024	BUY	$262.75 - $319.31 $256,969 - $312,285	978 Added 4.16%	24,500 $7.66 Million
Q1 2024 May 06, 2024	BUY	$268.87 - $324.56 $266,181 - $321,314	990 Added 4.39%	23,522 $6.69 Million
Q4 2023 Feb 06, 2024	BUY	$255.7 - $288.46 $3.03 Million - $3.42 Million	11,854 Added 111.01%	22,532 $6.49 Million
Q3 2023 Nov 07, 2023	SELL	$218.65 - $271.46 $2.56 Million - $3.18 Million	-11,723 Reduced 52.33%	10,678 $2.87 Million
Q2 2023 Aug 08, 2023	SELL	$214.27 - $253.37 $168,201 - $198,895	-785 Reduced 3.39%	22,401 $4.97 Million
Q1 2023 May 08, 2023	SELL	$225.79 - $275.2 $312,041 - $380,326	-1,382 Reduced 5.63%	23,186 $5.61 Million
Q4 2022 Feb 10, 2023	SELL	$229.03 - $291.01 $63,441 - $80,609	-277 Reduced 1.11%	24,568 $6.45 Million
Q3 2022 Nov 07, 2022	BUY	$224.46 - $253.15 $72,276 - $81,514	322 Added 1.31%	24,845 $5.6 Million
Q2 2022 Aug 05, 2022	BUY	$230.71 - $256.74 $35,298 - $39,281	153 Added 0.63%	24,523 $5.97 Million
Q1 2022 May 06, 2022	BUY	$219.27 - $242.57 $87,927 - $97,270	401 Added 1.67%	24,370 $5.89 Million
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $86,115 - $98,550	433 Added 1.84%	23,969 $5.39 Million
Q3 2021 Nov 10, 2021	SELL	$212.27 - $248.7 $79,813 - $93,511	-376 Reduced 1.57%	23,536 $5.01 Million
Q2 2021 Aug 10, 2021	BUY	$233.58 - $259.14 $40,642 - $45,090	174 Added 0.73%	23,912 $5.83 Million
Q1 2021 May 12, 2021	SELL	$221.91 - $258.6 $11,761 - $13,705	-53 Reduced 0.22%	23,738 $5.91 Million
Q4 2020 Feb 10, 2021	SELL	$216.38 - $257.67 $455,912 - $542,910	-2,107 Reduced 8.14%	23,791 $5.47 Million
Q3 2020 Nov 10, 2020	SELL	$234.65 - $260.95 $145,013 - $161,267	-618 Reduced 2.33%	25,898 $6.58 Million
Q2 2020 Aug 11, 2020	BUY	$197.81 - $242.74 $144,796 - $177,685	732 Added 2.84%	26,516 $6.26 Million
Q1 2020 May 04, 2020	SELL	$182.24 - $241.7 $700,530 - $929,094	-3,844 Reduced 12.97%	25,784 $5.23 Million
Q4 2019 Feb 05, 2020	SELL	$189.21 - $243.2 $319,954 - $411,251	-1,691 Reduced 5.4%	29,628 $7.14 Million
Q3 2019 Nov 08, 2019	SELL	$174.11 - $208.62 $550,709 - $659,865	-3,163 Reduced 9.17%	31,319 $6.06 Million
Q2 2019 Aug 13, 2019	SELL	$166.7 - $195.41 $1.95 Million - $2.28 Million	-11,692 Reduced 25.32%	34,482 $6.36 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $105,085 - $118,454	581 Added 1.27%	46,174 $8.77 Million
Q4 2018 Feb 11, 2019	SELL	$178.4 - $208.25 $50,844 - $59,351	-285 Reduced 0.62%	45,593 $8.88 Million
Q3 2018 Nov 08, 2018	SELL	$185.29 - $208.89 $2.13 Million - $2.41 Million	-11,518 Reduced 20.07%	45,878 $9.51 Million
Q2 2018 Aug 03, 2018	SELL	$166.05 - $186.51 $267,672 - $300,654	-1,612 Reduced 2.73%	57,396 $10.6 Million
Q1 2018 May 11, 2018	SELL	$169.43 - $198.0 $259,058 - $302,742	-1,529 Reduced 2.53%	59,008 $10.1 Million
Q4 2017 Feb 12, 2018	BUY	$168.79 - $188.59 $1.13 Million - $1.26 Million	6,679 Added 12.4%	60,537 $10.5 Million
Q3 2017 Nov 09, 2017	SELL	$167.29 - $191.0 $206,101 - $235,312	-1,232 Reduced 2.24%	53,858 $10 Million
Q2 2017 Aug 10, 2017	BUY	N/A	55,090	55,090 $9.49 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of South State Corp, based on Form 13F filings with the SEC.

News

Stay updated on South State Corp with notifications on news.

Account